Oscar Health Inc Research Report - FY2023 Q4

FY2023 Q4: Pivots to Profitable Growth, Guiding to $125M-$175M Adj. EBITDA in 2024 on Strong Membership Rebound to 1.3M+

Sign in required

Sign in or create an account to continue to this document.

Pic
dbot